SUMMARY Renal abnormalities in 132 necropsied patients with rheumatoid arthritis were studied. Clinical findings before death included extra-articular manifestations of the disease (86% of patients), systemic vasculitis (6%), and uraemia (23%). Necropsy findings included nephrosclerosis (90%), systemic vasculitis (14%) with kidney involvement in 8%, amyloidosis (11%), membranous glomerulopathy (8%), and focal glomerular disease (8%). Association with clinical data suggests that both rheumatoid and non-rheumatoid disease may play a part in the cause of these abnormalities.
Renal involvement in rheumatoid arthritis (RA) is well recorded. Involvement leading to loss of renal function is mainly attributed to the development of amyloidosis or to adverse reactions to drug treatment,1-5 and in a few cases to rheumatoid vasculitis affecting the renal vessels.6 7 Several necropsy and biopsy studies have shown non-specific kidney changes, which were ascribed to RA. The lesions included non-specific changes such as mesangial hypercellularity,8-6 nephrosclerosis,8 13 1417-19 and the incidental finding of proliferative glomerulonephritis2" 21 or membranous glomerulopathy22 attributable only to the rheumatoid disease. It is not certain, however, whether these lesions must be considered a part of the rheumatoid disease because the association was not found by all of the authors,'7 [23] [24] [25] [26] and disease other than RA underlying the renal abnormalities cannot always be ruled out.
The aim of the present study was to evaluate the renal abnormalities in a large series of necropsied patients with RA and to detect correlations between these findings and possibly predictive clinical data. Amyloidosis, membranous glomerulopathy, proliferative glomerulonephritis, and renal vasculitis, but also non-specific changes in glomeruli, blood Acccptcd for publication 13 vessels, and the interstitium, were present in a significant proportion of our patients. The occurrence of some of these findings was shown to be related to clinical aspects of RA and concomitant (non-rheumatic) disease.
Patients and methods
The series comprises all cases of classical or definitive RA treated and necropsied in our hospital between 1958 proliferative glomerulonephritis in two. In the five patients with proliferative glomerulonephritis but without systemic vasculitis, only one had diffuse glomerulonephritis, and four showed local focal glomerulonephritis.
Membranous glomerulopathy was observed in nine patients; in two, systemic vasculitis was found at necropsy as well, but without evidence of renal involvement. Focal glomerulosclerosis was noted in five patients (with concomitant amyloidosis in one), and membranoproliferative glomerulonephritis in one.
Lesions of tubuli and interstitium Specific lesions of tubuli and interstitium were scarce; there were three patients with tubulointerstitial nephritis, and two with acute tubular necrosis.
Benign nephrosclerosis
Benign nephrosclerosis with characteristic changes in glomeruli and larger renal vessels was found in 119 patients (90%); non-specific tubulointerstitial changes were found in 54 patients (41%).
CLINICOPATHOLOGICAL CORRELATIONS
Patients with amyloidosis had RA of longer duration (p<0-01) than patients without this finding. Moreover, proteinuria and uraemia were found more frequently in the presence of amyloidosis; both occurred in 11 of 14 patients (for both, p<0.001).
The presence of systemic vasculitis (with or without renal involvement) at necropsy was associated with the occurrence of other extraarticular manifestations before death (p<0-01), as shown in Fig. 1 . In patients with vasculitis, renal function loss occurred only where renal vessels were also affected, and uraemia only when proliferative glomerulonephritis was present (Fig. 2) Severity of benign nephrosclerosis was positively related to age (p=005), duration of RA (p<0O01), and occurrence of hypertension, arteriosclerosis, and/or diabetes (each, p<005), but not to renal function. Age and duration of RA were not interrelated (p>0-70). The presence of non-specific changes in tubuli and interstitium was positively related not only to the presence of hypertension (p<0-01), but also to the creatinine level during the Table 4 .
No statistically significant relations, apart from those just mentioned, were found between a renal lesion and a given treatment modality or any other clinical parameter. It must be kept in mind, however, that all patients with systemic vasculitis and all those with membranous glomerulopathy had been treated with gold or D-penicillamine, or both.
Discussion
The results of this study show a high incidence of heterogeneous renal disease leading to uraemia in a group of necropsied patients with RA. Correlations with clinical data suggested that both RA and concomitant disease play a part in the aetiology of these lesions.
The prevalence of well known renal complications of RA, notably amyloidosis and membranous glomerulopathy, was similar to that reported by other authors. -4 The relation between the presence of amyloidosis and the duration of RA, uraemia, and proteinuria was confirmed. Membranous glomerulopathy was found only in patients previously treated with gold or D-penicillamine, or both, but this relation was not statistically significant, probably owing to the large proportion of patients given such treatment. It must be remembered that some cases of membranous glomerulopathy will probably have been overlooked (in this and other necropsy studies) because immunofluorescence and electron microscopy techniques were not applied. The high incidence of benign nephrosclerosis in the present study can probably be ascribed mainly to concomitant disease. In a necropsy series of 150 'unselected' patients studied to assess the relation between hypertension and renal abnormalities, almost all of the patients had nephrosclerotic changes; the severity was strongly correlated with the presence of hypertension.32 In our patients the severity of the lesions was related to the presence of hypertension, diabetes mellitus, and arteriosclerosis. The finding of a clear relation between the severity of nephrosclerosis and the duration of RA remains unexplained, however, and suggests that RA or therapy is an additional factor in the aetiology of nephrosclerosis. We found no other non-specific renal abnormality, for example mesangial hypercellularity, that has been ascribed to RA. Subtle changes could easily have been 'hidden', however, among the nephrosclerotic lesions.
Our series is remarkable for the number of glomerular lesions not usually associated with RA, i.e., proliferative glomerulonephritis, focal glomerulosclerosis, and membranoproliferative glomerulonephritis. Proliferative glomerulonephritis has been reported incidentally in patients with RA14 20 21 33 34 and has been attributed to vasculitis and gold therapy. Six ofour patients had glomerulonephritis associated with systemic vasculitis, but five had glomerulonephritis without evidence of vasculitis. Two of these five had not been treated with gold or D-penicillamine. To our knowledge membranoproliferative glomerulonephritis has not been reported before in patients with RA. In the necro?sy study of 'normal' patients by Tracy and Toca3 glomerulonephritis and focal sclerosis were found in less than 1%. Thus the high incidence of glomerular lesions in our patients in comparison with these 'controls' suggests a previously unrecognised association of certain renal lesions with RA.
In summary, our study confirms the view that the kidney is frequently damaged in the course of a lifetime with RA. The scope of renal disease in RA encompasses well known entities such as amyloidosis, vasculitis, and membranous glomerulopathy, but may be wider and include other forms of glomerulopathy and benign nephrosclerosis. The associations between renal abnormalities and clinical data suggest that RA contributes to the renal damage caused by concomitant disease.
